Atlas Trials

Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR

Clinical trial NCT00879307 · UNKNOWN

Trial details

NCT number
NCT00879307
Sponsor
Hospital de Clinicas de Porto Alegre
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
BIPOLAR DISORDER
Start date
2009-03-01
Primary completion
2011-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.